NanoString and Cancer Immunotherapy Trials Network enter into collaboration
The Cancer Immunotherapy Trials Network and NanoString Technologies announced a multi-year translational research collaboration to discover biomarkers that predict clinical outcomes for cancer immunotherapies, both as single agents and in combination. May 05, 2015